Advertisement
Z Squared Inc.

Z Squared Inc. Fundamental Analysis

ZSQRNASDAQ
TechnologySoftware - Services
$7.04
$1.45(17.08%)
U.S. Market opens in 13h 35m
Advertisement

Z Squared Inc. Fundamental Analysis

Z Squared Inc. (ZSQR) shows weak financial fundamentals with a PE ratio of -2.90, profit margin of -8.32%, and ROE of -82.93%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.04
Current Ratio3.25

Areas of Concern

ROE-82.93%
Operating Margin-9.12%
We analyze ZSQR's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -849.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-849.1/100

We analyze ZSQR's fundamental strength across five key dimensions:

Efficiency Score

Weak

ZSQR struggles to generate sufficient returns from assets.

ROA > 10%
-50.21%

Valuation Score

Excellent

ZSQR trades at attractive valuation levels.

PE < 25
-2.90
PEG Ratio < 2
-0.04

Growth Score

Weak

ZSQR faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

ZSQR maintains a strong and stable balance sheet.

Debt/Equity < 1
0.02
Current Ratio > 1
3.25

Profitability Score

Weak

ZSQR struggles to sustain strong margins.

ROE > 15%
-8292.67%
Net Margin ≥ 15%
-8.32%
Positive Free Cash Flow
N/A

Key Financial Metrics

Is ZSQR Expensive or Cheap?

P/E Ratio

ZSQR trades at -2.90 times earnings. This suggests potential undervaluation.

-2.90

PEG Ratio

When adjusting for growth, ZSQR's PEG of -0.04 indicates potential undervaluation.

-0.04

Price to Book

The market values Z Squared Inc. at 2.06 times its book value. This may indicate undervaluation.

2.06

EV/EBITDA

Enterprise value stands at -4.43 times EBITDA. This is generally considered low.

-4.43

How Well Does ZSQR Make Money?

Net Profit Margin

For every $100 in sales, Z Squared Inc. keeps $-8.32 as profit after all expenses.

-8.32%

Operating Margin

Core operations generate -9.12 in profit for every $100 in revenue, before interest and taxes.

-9.12%

ROE

Management delivers $-82.93 in profit for every $100 of shareholder equity.

-82.93%

ROA

Z Squared Inc. generates $-50.21 in profit for every $100 in assets, demonstrating efficient asset deployment.

-50.21%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-1.33 in free cash annually.

$-1.33

FCF Yield

ZSQR converts -18.28% of its market value into free cash.

-18.28%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-2.90

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.04

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.06

vs 25 benchmark

P/S Ratio

Price to sales ratio

31.25

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.02

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.25

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.83

vs 25 benchmark

ROA

Return on assets percentage

-0.50

vs 25 benchmark

ROCE

Return on capital employed

-0.60

vs 25 benchmark

How ZSQR Stacks Against Its Sector Peers

MetricZSQR ValueSector AveragePerformance
P/E Ratio-2.9036.56 Better (Cheaper)
ROE-82.93%717.00% Weak
Net Margin-832.32%-141409.00% (disorted) Weak
Debt/Equity0.020.46 Strong (Low Leverage)
Current Ratio3.253.41 Strong Liquidity
ROA-50.21%198.00% Weak

ZSQR outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Z Squared Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Growth, Innovation, High Beta

EPS CAGR

N/A

Industry Style: Growth, Innovation, High Beta

FCF CAGR

N/A

Industry Style: Growth, Innovation, High Beta

Fundamental Analysis FAQ